MHES0488A
MHES0488A is a selective humanized antibody that targets HER2 with a KD value of 0.8 nM. MHES0488A is an antibody part of DHES0815A. MHES0488A is internalized by cells and transported to lysosomes, and then releases PBD-monoamide that enters the nucleus, alkylates DNA and induces DNA damage and apoptosis. MHES0488A is promising for research of cancers, such as HER2-positive breast cancer and gastric cancer[1].
Product Specifications
Product Name Alternative
DHES0815A antibody; RG-6148 antibody
UNSPSC
12352203
Target
DNA Alkylator/Crosslinker; EGFR
Related Pathways
Cell Cycle/DNA Damage; JAK/STAT Signaling; Protein Tyrosine Kinase/RTK
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Smiles
[MHES0488A]
References & Citations
[1]Lewis G, et al. Development of DHES0815A; a novel HER2-directed antibody-drug conjugate comprised of a reduced potency mono-alkylating agent linked to a domain I binding HER2 antibody[J]. 2022.
Shipping Conditions
Room temperature
Scientific Category
Inhibitory Antibodies
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
GTR10439627 96 Well
Sheep Neuronal apoptosis inhibitory protein ELISA kit
Sign In for Pricing
View Details 
bsm-41267M-Cy5-01 20 µL
SARS-CoV-2 (2019-nCoV) Nucleocapsid (1G4) Monoclonal Antibody, Cy5 Conjugated
Sign In for Pricing
View Details